NCT07804329

Brief Summary

In these recent years, Intermittent Fasting (IF) has become popular among the public and health fraternities not only because it produced evidence-based results as an alternative dietary approach in weight loss strategy, but also putative for its practical implementation to link with daily routine. IF is defined as a range of dietary regimens involving fasting for an extended time period (16-48hrs) with little to no energy intake on fast day. However, there are many types of IF regiments with different methodological approaches, and results are inconsistent and debatable. Therefore, it has raised a question on which IF regimen design will possibly maximise the health benefit. Thus, the aim of this study is to identify IF regimens that are most feasible and acceptable to working women. The purpose of this study was to examine which type of IF regiment is more feasible for weight loss intervention programmes by prescribing three different types of IF to participants

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

August 12, 2026

Completed
23 days until next milestone

First Posted

Study publicly available on registry

September 4, 2026

Completed
Last Updated

September 4, 2026

Status Verified

July 1, 2026

Enrollment Period

2 months

First QC Date

August 12, 2026

Last Update Submit

August 31, 2026

Conditions

Keywords

Intermittent FastingTime Restricted EatingModified Alternate Day FastingPeriodic FastingAdherenceQuality of Life

Outcome Measures

Primary Outcomes (1)

  • Adherence Percentage

    Number of days adhered to daily energy requirement divided by total of intervention days. Adherence Percentage = (No. of days adhered to daily energy requirement/No. of intervention days)\*100

    Daly throughout 4 weeks of intervention. From Day 1 until Day 28

Secondary Outcomes (1)

  • Anthropometry and Body Composition

    Pre and post-measurement. Measured at baseline (Day 1), and post-intervention (Day 28)

Other Outcomes (1)

  • Health-related Quality of Life (HQoL)

    Measured at post-intervention only, at the end of 4 week of intervention, on day 28.

Study Arms (3)

MADF

EXPERIMENTAL

Different types of intermittent fasting protocol

Other: Adherence to the IF ProtocolOther: Quality of Life

TRE

EXPERIMENTAL

Type of IF

Other: Adherence to the IF ProtocolOther: Quality of Life

PF5:2

EXPERIMENTAL

Typr of IF

Other: Adherence to the IF ProtocolOther: Quality of Life

Interventions

Adherence Percentage

Also known as: Adherence Percentage
MADFPF5:2TRE

Survey of PCS and MCS Score

MADFPF5:2TRE

Eligibility Criteria

Age25 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWorking adult women aged 25-50 years were recruited through on-campus flyers and digital advertisements.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • a body mass index (BMI) of 27.5-32.4 kg/m² (obesity class I), low physical activity levels (\<150 minutes/week), and no prior participation in health or diet-related programs.

You may not qualify if:

  • Women who were pregnant, had cardiovascular disease or a history of eating disorders were excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Sports and Exercise Science

Kuala Lumpur, 50603, Malaysia

Location

Related Publications (6)

  • Varady KA, Cienfuegos S, Ezpeleta M, Gabel K. Clinical application of intermittent fasting for weight loss: progress and future directions. Nat Rev Endocrinol. 2022 May;18(5):309-321. doi: 10.1038/s41574-022-00638-x. Epub 2022 Feb 22.

    PMID: 35194176BACKGROUND
  • Allaf M, Elghazaly H, Mohamed OG, Fareen MFK, Zaman S, Salmasi AM, Tsilidis K, Dehghan A. Intermittent fasting for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013496. doi: 10.1002/14651858.CD013496.pub2.

    PMID: 33512717BACKGROUND
  • Antoni R, Johnston KL, Collins AL, Robertson MD. Intermittent v. continuous energy restriction: differential effects on postprandial glucose and lipid metabolism following matched weight loss in overweight/obese participants. Br J Nutr. 2018 Mar;119(5):507-516. doi: 10.1017/S0007114517003890.

    PMID: 29508693BACKGROUND
  • Welton S, Minty R, O'Driscoll T, Willms H, Poirier D, Madden S, Kelly L. Intermittent fasting and weight loss: Systematic review. Can Fam Physician. 2020 Feb;66(2):117-125.

    PMID: 32060194BACKGROUND
  • Zang BY, He LX, Xue L. Intermittent Fasting: Potential Bridge of Obesity and Diabetes to Health? Nutrients. 2022 Feb 25;14(5):981. doi: 10.3390/nu14050981.

    PMID: 35267959BACKGROUND
  • 1. Lean MEJ. Management of obesity and overweight. Medicine (Baltimore). 2019;47(3):175-183. https://doi.org/10.1016/j.mpmed.2018.12.008

    BACKGROUND

Related Links

MeSH Terms

Conditions

Intermittent Fasting

Interventions

Quality of Life

Condition Hierarchy (Ancestors)

FastingFeeding BehaviorBehavior

Intervention Hierarchy (Ancestors)

Health StatusDemographyEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Study Officials

  • Sareena Hanim Hamzah, Associate Proffesor

    Faculty of Sports and Exercise Science

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Model Details: Randomised control trials. participant is randomised sigle blinded to one of the intermittent fasting protocols (TRE, MADF or PF5:2)
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PHD Student

Study Record Dates

First Submitted

August 12, 2026

First Posted

September 4, 2026

Study Start

April 1, 2023

Primary Completion

June 1, 2023

Study Completion

June 30, 2023

Last Updated

September 4, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

This study was conducted in Apr 2023

Locations